Treatment response summary for anti-cancer activity of MPT0E028 and SAHA in the human HCT116 colorectal cancer xenograft model.

n = number of animals; Study Endpoint = 1200 mm3, Days in Progress = 60; TTE = time to endpoint; T-C = difference between median TTE (days) of treated versus control group; %TGD (tumor growth delay) = [(T-C)/C]×100; CR = complete regression; Statistical Significance = Logrank test; ns = not significant; * = P<0.05 compare with control. qd = once daily; po = oral administration.